National Institute of Health (NIH), of the US Department of Health offers the drug repurposing and gaining new approvals along with widening usage of the drug repurposing. It has numerous potential opportunities for growth by catering the unmet medical needs with some cost-effective solutions as alternative to the expensive drugs.
The global drug repurposing market report from Transparency market ... Read more
Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007–2009, 30–40% of them were the drugs repurposed or repositioned. National Institute of Health (NIH), U.S. Department of Health defines drug repurposing as discovering new uses for approved drugs to provide the quickest possible transition from bench to ... Read more
